




Abacavir Sulphate Tablets General Drugs
Price:
Get Latest Price
Minimum Order Quantity :
500 Box
Brand Name :
Facmed Pharmaceuticals
In Stock
Product Specifications
Pacakaging (Quantity Per Box) | 30 tablets per box |
Indication | Abacavir tablets USP 300 mg, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (HIV-1) infection. The recommended dosage of abacavir sulfate for adults is 600 mg daily, administered orally as either 300 mg twice daily or 600 mg once daily, in combination with other antiretroviral agents. The recommended dosage of abacavir sulfate in HIV-1-infected pediatric patients aged 3 months and older is 8 mg per kg orally twice daily (up to a maximum of 600 mg daily) in combination with other antiretroviral agents. |
Salt Composition | Abacavir tablets USP 300 mg, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (HIV-1) infection. The recommended dosage of abacavir sulfate for adults is 600 mg daily, administered orally as either 300 mg twice daily or 600 mg once daily, in combination with other antiretroviral agents. The recommended dosage of abacavir sulfate in HIV-1-infected pediatric patients aged 3 months and older is 8 mg per kg orally twice daily (up to a maximum of 600 mg daily) in combination with other antiretroviral agents. |
Origin of Medicine | India |
Dosage Form | Tablets |
Drug Type | Specific Drug |
Formulations Type | General Drugs |
Ingredients | Abacavir tablets USP 300 mg, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (HIV-1) infection. The recommended dosage of abacavir sulfate for adults is 600 mg daily, administered orally as either 300 mg twice daily or 600 mg once daily, in combination with other antiretroviral agents. The recommended dosage of abacavir sulfate in HIV-1-infected pediatric patients aged 3 months and older is 8 mg per kg orally twice daily (up to a maximum of 600 mg daily) in combination with other antiretroviral agents. |
Formulations Form | Tablets |
Physical Form | Tablets |
Function | Anti-Viral |
Recommended For | Abacavir tablets USP 300 mg, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (HIV-1) infection. The recommended dosage of abacavir sulfate for adults is 600 mg daily, administered orally as either 300 mg twice daily or 600 mg once daily, in combination with other antiretroviral agents. The recommended dosage of abacavir sulfate in HIV-1-infected pediatric patients aged 3 months and older is 8 mg per kg orally twice daily (up to a maximum of 600 mg daily) in combination with other antiretroviral agents. |
Dosage | Abacavir tablets USP 300 mg, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (HIV-1) infection. The recommended dosage of abacavir sulfate for adults is 600 mg daily, administered orally as either 300 mg twice daily or 600 mg once daily, in combination with other antiretroviral agents. The recommended dosage of abacavir sulfate in HIV-1-infected pediatric patients aged 3 months and older is 8 mg per kg orally twice daily (up to a maximum of 600 mg daily) in combination with other antiretroviral agents. |
Dosage Guidelines | As per physician |
Suitable For | Adults, Suitable For All |
Quantity | 300mg Boxes |
Storage Instructions | Store it at room temperature |
Payment Terms | Cash in Advance (CID) |
Supply Ability | 500000 Per Month |
Delivery Time | 30 Days |
Sample Policy | Sample costs shipping and taxes has to be paid by the buyer |
Packaging Details | Abacavir tablets USP 300 mg tablet is packed in box and customized packaging is also available. |
Main Export Market(s) | Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa |
Main Domestic Market | All India |
Certifications | WHO,GMP,ISO |
Product Overview
Key Features
Related Products
More Product From This seller
Company Details
Founded in the year 2017, We, Facmed Pharmaceuticals Pvt. Ltd. are an emerging pharmaceutical organization with proven capabilities in the area of Manufacturing, Exporting, Trading and Supplying different kinds of pharmaceutical products. We deal in different kinds of Pharmaceuticals Products, Medical Devices, Veterinary Products & Food Supplements, Herbal Products & Nutritional Supplements etc. We apply a unique combination of expertise in the field of healthcare and believe in bringing new ideas for preparing medical products which are very beneficial for health conscious clients.
Business Type
Exporter, Manufacturer, Trading Company
Employee Count
10
Establishment
2017
Working Days
Monday To Saturday
GST NO
07AADCF1478P1Z5
Certification
ISO 9001:2015
Explore Related Categories
Seller Details
GST - 07AADCF1478P1Z5
New Delhi, Delhi
Bd, Ra & Qa.
Mr Puneet Kumar
Members since
8 Years
Address
S/F, Plot No. B-133-134, Nanhey Park, Kh No 18/20, Uttam Nagar, New Delhi, Delhi, 110059, India
Report incorrect details